Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
The muscarinic cholinergic system regulates peripheral and central nervous system functions, and, thus, their potential as a therapeutic target for several neurodegenerative diseases is undoubted. A clinically applicable positron emission tomography (PET) tracer would facilitate the monitoring of di...
Main Authors: | Marius Ozenil, Jonas Aronow, Marlon Millard, Thierry Langer, Wolfgang Wadsak, Marcus Hacker, Verena Pichler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/6/530 |
Similar Items
-
Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M<sub>1</sub> Antagonists
by: Jonas Kilian, et al.
Published: (2022-02-01) -
Synthesis, Biological Evaluation, and Docking Studies of Antagonistic Hydroxylated Arecaidine Esters Targeting mAChRs
by: Jonas Kilian, et al.
Published: (2022-05-01) -
Allosteric Modulation of Muscarinic Acetylcholine Receptors
by: Esam E. El-Fakahany, et al.
Published: (2010-08-01) -
Role of Muscarinic Acetylcholine Signaling in Gastrointestinal Cancers
by: Mitsuru Konishi, et al.
Published: (2019-08-01) -
Muscarinic Acetylcholine Receptors in the Retina—Therapeutic Implications
by: Yue Ruan, et al.
Published: (2021-05-01)